| Title : Clopidogrel Bioactivation and Risk of Bleeding in Patients Cotreated With Angiotensin-Converting Enzyme Inhibitors After Myocardial Infarction: A Proof-of-Concept Study - Kristensen_2014_Clin.Pharmacol.Ther_96_713 |
| Author(s) : Kristensen KE , Zhu HJ , Wang X , Gislason GH , Torp-Pedersen C , Rasmussen HB , Markowitz JS , Hansen PR |
| Ref : Clinical Pharmacology & Therapeutics , 96 :713 , 2014 |
| Abstract : Kristensen_2014_Clin.Pharmacol.Ther_96_713 |
| ESTHER : Kristensen_2014_Clin.Pharmacol.Ther_96_713 |
| PubMedSearch : Kristensen_2014_Clin.Pharmacol.Ther_96_713 |
| PubMedID: 25222620 |
Kristensen KE, Zhu HJ, Wang X, Gislason GH, Torp-Pedersen C, Rasmussen HB, Markowitz JS, Hansen PR (2014)
Clopidogrel Bioactivation and Risk of Bleeding in Patients Cotreated With Angiotensin-Converting Enzyme Inhibitors After Myocardial Infarction: A Proof-of-Concept Study
Clinical Pharmacology & Therapeutics
96 :713
Kristensen KE, Zhu HJ, Wang X, Gislason GH, Torp-Pedersen C, Rasmussen HB, Markowitz JS, Hansen PR (2014)
Clinical Pharmacology & Therapeutics
96 :713